GSK shares tumble 9% after Zantac ruling | REUTERS

Shares of GSK dropped more than 9% after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker.

#News #GSK #USA #UK #Zantac #Reuters #Newsfeed

Read the story here: https://reut.rs/3X6o4p0

Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en